DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
People / Rebecca Luse
Rebecca Luse
Roles
1 current, 0 past
- Deep Track Capital Managing Director? to present · “said Rebecca Luse, Managing Director at Deep Track Capital.”
Investments attributed to this person
1
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Attovia Therapeutics | Series C · $90.0M · Series C | Deep Track Capital | confirmed | Apr 15, 2025 | Fact globenewswire.com |
Board seats and vehicles
1 boards, 0 vehicles
- Imbria Pharmaceuticals, Inc. Director Apr 1, 2025 Fact
Timeline
0
No dated event.